Macular Edema and Macular Degeneration Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

"How Big Is the Macular Edema and Macular Degeneration Market Expected to Be, and What Will Its Growth Rate Be?
The macular edema and macular degeneration market has seen significant growth in recent years. It will expand from $9.65 billion in 2024 to $10.43 billion in 2025, with a CAGR of 8.1%. Factors contributing to this growth include the aging population, increasing diabetes prevalence, early diagnosis and awareness, global initiatives in eye health, pharmaceutical innovations, and patient advocacy.

The Macular Edema and Macular Degeneration market will reach $13.71 billion by 2029, growing at a CAGR of 7.1%, driven by personalized medicine, combination therapies, and aging demographics. Key trends include sustained-release drug delivery, gene therapies, novel imaging technologies, and AI for diagnostics.

What Are the Primary Growth Drivers for the Macular Edema and Macular Degeneration Market?
The rising diabetes population is expected to fuel the growth of the macular edema and macular degeneration market. Diabetes is a chronic condition that causes high blood sugar levels and damages the blood vessels in the eye, leading to conditions like macular edema and macular degeneration. For example, in June 2024, NHS England reported an 18% increase in the number of pre-diabetes cases, with 3,615,330 people affected in 2023. Among individuals under 40, cases grew by nearly 25%, from 173,166 in 2022 to 216,440 in 2023. Therefore, the rising diabetes population is driving the growth of the macular edema and macular degeneration market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13479&type=smp

Who Are the Dominant Companies Influencing Macular Edema and Macular Degeneration Market Trends?
Major companies operating in the macular edema and macular degeneration market report are F. Hoffmann La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, GlaxoSmithKline PLC, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Bausch Health Companies Inc., Clover Therapeutics Inc., Santen Pharmaceutical Co. Ltd., Samsung Bioepis Inc., PanOptica Inc., Regen X Bio Inc., Aerie Pharmaceutical Inc., Apellis Pharmaceuticals Inc., Kubota Pharmaceutical Holdings Co. Ltd., Alimera Sciences Inc., Kodiak Sciences Inc., Acucela Inc., Editas Medicine Inc., IVERIC bio Inc., Lineage Cell Therapeutics Inc., Allegro Ophthalmic Ltd., Ampio Pharmaceuticals Inc., Neurotech Pharmaceuticals Inc., Graybug Vision Inc., Clearside Biomedical Inc., Ocugen Inc., Opthea Limited

How Is the Macular Edema and Macular Degeneration Market Evolving?
In the macular edema and macular degeneration market, companies are focusing on developing innovative treatments like Vabysmo (faricimab-svoa) to increase their market share. Vabysmo is used for treating neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). For example, in January 2022, Genentech Inc., a US-based biotechnology firm, received FDA approval for Vabysmo, a bispecific antibody that targets VEGF and Ang-2. This approval marks a significant milestone for Genentech and Roche in treating these eye conditions.

What Are the Different Segmentations in the Macular Edema and Macular Degeneration Market?
The macular edema and macular degeneration market covered in this report is segmented -

1) By Treatment Type: Drug Therapy, Laser Treatment
2) By Application: Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry age-related macular degeneration, Wet age-related macular degeneration
3) By End User: Hospitals, Clinics, Other End Users

Subsegments:
1) By Drug Therapy: Anti-VEGF (Vascular Endothelial Growth Factor) Injections, Steroid Injections, Oral Medications, Combination Therapy (Anti-VEGF + Steroids)
2) By Laser Treatment: Focal Laser Photocoagulation, Panretinal Photocoagulation (PRP), Subthreshold Laser Therapy, MicroPulse Laser Therapy

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/macular-edema-and-macular-degeneration-global-market-report

Which Region Is at the Forefront of the Macular Edema and Macular Degeneration Market?
North America was the largest region in the macular edema and macular degeneration market in 2024. The regions covered in the macular edema and macular degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Macular Edema and Macular Degeneration Global Market Report?

- Market Size Analysis: Analyze the Macular Edema and Macular Degeneration Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Macular Edema and Macular Degeneration Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Macular Edema and Macular Degeneration Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Macular Edema and Macular Degeneration Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.